Home Finance A Bet That Definitely Worked; But Persistence Needed: Moleculin Biotech Inc. (MBRX)

A Bet That Definitely Worked; But Persistence Needed: Moleculin Biotech Inc. (MBRX)

Moleculin Biotech, Inc., (Nasdaq: MBRX) shares are trade -2.84% to $4.78. Based on the relationship between its 200-day and 20-day major moving averages, Moleculin Biotech Inc. (MBRX) has been in rally mode. MBRX shares have risen 4.72% in the past 30 days. Stocks have declined -7.98% over the trailing 12 months, outperforming the market by 262.16%. Its performance trailed competitor brands by 30.32 percent.

 Corporate Details


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Moleculin Biotech, Inc. develops vaccines to treat non-communicable diseases such as viral hepatitis and HIV.

Meanwhile, in the global biopharmaceutical industry, Catalyst offers highly customizable clinical research solutions, including Catalyst Flex and Catalyst Oncology. Through offices in the US and EU and over 500 staff, the company provides multitherapeutic global sourcing and functional services through Catalyst Flex, and a comprehensive oncology CRO service through Catalyst Oncology.

What just happened

Moleculin Biotech, Inc., (Nasdaq: MBRX) announced today that it has entered into a research agreement with Catalyst Clinical Research, Inc., a contract research organization, to manage its US clinical trial to study Annamycin’s ability to treat sarcomas that have spread to the lungs.

Approximately 130,000 incident sarcoma cases are reported every year through soft tissue sarcomas. The removal of many sarcomas can be accomplished by surgery, but as many as 20% to 50% will end up metastasizing to the lungs, in which case treatment becomes challenging.

Anthracycline doxorubicin, or Adriamycin, is the primary chemotherapy regimen used if tumors have spread to the lungs if surgical removal is not possible. Although 10 to 30% of patients with sarcoma lung metastases initially respond to doxorubicin, many will relapse, leaving them with no other option for treatment. Several anthracycline drugs, including doxorubicin, carry inherent cardiotoxicity, which further limits treatment options.

Approximately 34 times the concentration of doxorubicin has been found in the lungs of animals treated with annamycin. Moreover, Annamycin has also showed an absence of cardiotoxicity during human clinical trials focusing on acute myeloid leukemia, therefore it will not have to undergo the same dose restrictions imposed on doxorubicin.

Conclusion

Experts agree that drug development is at its peak in our lifetimes. Science is providing new insights into the prevention and treatment of diseases previously unknown. If approved by authorities, the pharmaceutical industry is likely to provide investors with huge returns.

 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Cue Biopharma, Inc. (NASDAQ:CUE) stock surged in the current trading session; here’s why

In the current trading session, at the last check, the CUE stock had surged by 29.88% to $14.62. CUE's stock previously closed at $11.26....

Conformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for Identity Imprint

Conformis, Inc. (CFMS) stock prices were up 5.9061% during the first half of the trading day on May 10th, 2021, bringing the price per...

Auris Medical Inc. (NASDAQ: EARS) stock rises during current market. Why is it so?

Auris Medical Inc. (NASDAQ: EARS) stock gains by 25.08% in the current market trading. Auris Medical is a clinical-stage pharmaceutical organization focused on developing...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam